CD8A and colorectal cancer: Effective immunotherapy in colorectal patients mainly exists in the tumor subsets of microsatellite instability (MSI-H) [5], which may be due to the presence of high density infiltrating CD8+T cells in MSI-H colorectal cancer tissues, leading to high levels of neoantigens and corresponding high immunogenicity [6].